Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial

"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.

Published On 2020-08-24 08:00 GMT   |   Update On 2020-08-24 08:11 GMT
Advertisement

New DelhiSerum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely false and conjectural.

"Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use", SII said in a statement.

"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.

Advertisement

"The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially", the statement said.

"Serum Institute of India, would like to clarify that the current claims surrounding Covishield's availability in the media are completely false and conjectural", it said.

The clarification came after reports that the vaccine would get commercialized in 73 days.

Read also: India Will Get COVID-19 Vaccine By 2020 End, Says Union Health Minister


Tags:    
Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News